The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Malam Akinolabar
Country: Portugal
Language: English (Spanish)
Genre: Relationship
Published (Last): 19 July 2009
Pages: 139
PDF File Size: 13.23 Mb
ePub File Size: 15.48 Mb
ISBN: 958-3-62803-218-5
Downloads: 46748
Price: Free* [*Free Regsitration Required]
Uploader: Maujas

Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium.

Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months.

Support Center Support Center. The Theory and Practice of Industrial Pharmacy.

Optimization of chlorphenesin emulgel formulation

As a general formulatikn, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and antifungal activity.


A study of shear and compression deformations on hydrophilic gels of tretinoin. Medical Applications of Controlled Release.

Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy. The influence of the type of the gelling agent and the concentration of both the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design. The Pharmaceutical Press; Analysis of data on the medicament release from ointments.

Formulation and evaluation of topical preparations containing phenol and local vesicants. Author information Article notes Copyright and License information Disclaimer. Marcel Dekker Inc; Transdermal controlled release systems.

Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: It emklgel found that the emulsifying agent concentration had the most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

Bioavailability of salbutamol sulphate from different suppository formulations. Formulation and stability of chloramphenicol gel and emulgel. This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. They also exhibited higher drug release and antifungal activity than fomrulation CHL powder. The drug release from all the emulgels was found to follow diffusion-controlled mechanism.

TOP Related Posts  6EP1336-3BA00 PDF

Commercially available CHL topical powder was used for comparison. Received Dec 31; Accepted May This article has been cited formulatiom other articles in PMC.

The Complete Drug Reference. All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value.

Optimization of chlorphenesin emulgel formulation

The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability. Lea and Febiger; Az J Pharm Sci. Blackwell Scientific Publications; Published online Sep 1.

Please review our privacy policy.

Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. Egypt J Pharm Sci. National Center for Biotechnology InformationU.